CAMC Clinical Trials Center

Charleston, West Virginia 25304

1 studies enrolling now · 20 studies all time

What they study most

Acute Kidney Injury, Aortic Stenosis, Severe, Atherosclerosis, Atrial Fibrillation, Bladder Cancer, Breast Cancer, Cancer, Carotid Artery Disease, Colo-rectal Cancer, Colorectal Cancer, Coronary Artery Disease, Covid19

Studies at this site

• IMPRoving Outcomes in Vascular DisEase - Aortic Dissection — Recruiting now
• Screening for High Frequency Malignant Disease — Running, not enrolling
• Post Approval Study (PAS) of the OPTIMIZER Smart and CCM Therapy — Running, not enrolling
• COVID-19 Thrombosis Prevention Trials: Post-hospital Thromboprophylaxis — Completed
• EARLY TAVR: Evaluation of TAVR Compared to Surveillance for Patients With Asymptomatic Severe Aortic Stenosis — Running, not enrolling
• Best Endovascular vs. Best Surgical Therapy in Patients With Critical Limb Ischemia — Completed
• Blood Sample Collection to Evaluate Biomarkers in Subjects With Untreated Solid Tumors — Completed
• Stool Collection Sub-Study of Exact Sciences Protocol 2018-01 — Completed
• GLORIA-AF Registry Program - Second and Third Phases — Completed
• Blood Sample Collection to Evaluate Biomarkers in Subjects With Untreated Hematologic Malignancies — Stopped early
• POST-APPROVAL STUDY of TRANSCAROTID ARTERY REVASCULARIZATION in PATIENTS With SIGNIFICANT CAROTID ARTERY DISEASE — Completed
• PLATINUM Diversity — Completed
• A Multicenter Study to Evaluate the ROX Coupler in Subjects With Hypertension — Stopped early
• NBI-98854 for the Treatment of Tardive Dyskinesia in Subjects With Schizophrenia or Schizoaffective Disorder — Completed
• Evaluation of the Effect on Glucose Control of AC2993 in Patients With Type 2 Diabetes Mellitus Treated With a Sulfonylurea — Completed
• Evaluation of the Effect on Glucose Control of AC2993 in Patients With Type 2 Diabetes Mellitus Treated With Metformin — Completed
• Extension Study for 2993-112 — Completed
• A Study to Evaluate the Safety and Efficacy of AC607 for the Treatment of Kidney Injury in Cardiac Surgery Subjects — Stopped early
• A 12 Week Study to Confirm the Effectiveness of 8mg of Fesoterodine Compared to 4mg of Fesoterodine — Completed
• DORADO - Fixed Doses of Darusentan as Compared to Placebo in Resistant Hypertension — Completed